Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)
|
|
- Noah Morrison
- 5 years ago
- Views:
Transcription
1 Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16. Note: The denominator includes only members who have ever responded to an EIN survey; 150 members who joined the EIN but have not yet responded to any surveys so far are excluded. Note: Not all respondents answered all questions, so totals for individual questions vary. Responders as percent of overall members in each category: Practice: Adult only 511 (42% of 1214 members) Pediatric only 166 (50% of 331 members) Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) Mid Atlantic 107 (48% of 224 members) East North Central 105 (44% of 236 members) West North Central 66 (43% of 155 members) South Atlantic 121 (43% of 280 members) East South Central 36 (44% of 81 members) West South Central 42 (42% of 101 members) Mountain 44 (45% of 97 members) Pacific 119 (41% of 292 members) Puerto Rico 2 (67% of 3 members) Canada 8 (38% of 21 members) Years experience since ID fellowship: <5 years 161 (42% of 387 members) (38% of 543 members) 15-24* 161 (50% of 323 members) (50% of 344 members) Employment: Hospital/clinic 208 (43% of 489 members) Private/group practice 169 (42% of 398 members) University/medical school 276 (44% of 623 members) VA and military 42 (55% of 77 members) State gov t 6 (60% of 10 members) Primary hospital type: Community Non-university teaching University VA hospital or DOD City/county 157 (38% of 414 members) 178 (44% of 409 members) 292 (47% of 625 members) 45 (52% of 87 members) 29 (47% of 62 members) *Respondents were significantly more likely than non-respondents to have at least 15 years of ID experience (p=0.0004), have pediatric practices (p=0.03), and not work at community hospitals (p=0.04). Page 1
2 Agents in Short Supply and Clinical Outcomes Question 1. Have you needed to modify your antimicrobial choice for treating or preventing an infectious disease because of a drug shortage within the past 2 years? Yes 491 (70%) No 210 (30%) Answered by 701 respondents Most of the 210 respondents who responded No opted out of answering any further questions, but data from the 5 who did answer the remaining questions are included below. Respondents who were least likely to report needing to modify their antimicrobial choice because of a drug shortage worked: --for the federal government, U.S. military, or state/local government (p=0.01), or --in a VA or Dept of Defense hospital or a community hospital (p=0.048). Question 2. The top antimicrobial agent(s) in short supply within the past 2 years: [Answers were typed into an open-text field, and are shown here in order of frequency mentioned] piperacillin-tazobactam (Zosyn) 298 ampicillin-sulbactam (Unasyn) 103 meropenem 98 cefotaxime 77 (70/77 have pediatric practices) cefepime 63 trimethoprim-sulfamethoxazole (Bactrim) 56 doxycycline 41 imipenem 40 acyclovir 40 amikacin 22 pyrimethamine 18 penicillin 16 cefazolin 14 vancomycin 13 aztreonam 11 tigecycline 10 Agents each mentioned by fewer than 10 respondents: albendazole, amoxicillin-clavulanate suspension, ampicillin, anidulafungin, atovaquone (Malarone), azithromycin, cefixime, cefotetan, cefoxitin, ceftaroline, ceftazidime, ceftazidime-avibactam, ceftriaxone, cefuroxime, cephalexin, chloramphenicol, chloroquine, cidofovir, clindamycin, daptomycin, doripenem, ertapenem, ethambutol, fluconazole IV, flucytosine, foscarnet, ganciclovir, gentamicin, isoniazid, levofloxacin IV, linezolid oral, mebendazole, metronidazole IV, moxifloxacin, mupirocin, nafcillin, Odefsey (emtricitabine/tenofovir/alafenamide), oseltamivir suspension, pentamidine (inhaled), peramivir, polymyxin, praziquantel, rifampin IV, rifapentine, telavancin, tetracycline, ticarcillin-clavulanate, tobramycin, voriconazole IV Page 2
3 Question 3. Has this shortage(s) and any resulting change in treatment affected patient care or outcomes in your opinion? Yes 358 (73%) No 132 (27%) Answered by 490 respondents Adverse effects that occurred because of the shortage(s): [Instructions were to select all that apply; numbers add to more than 100%; 358 respondents] Use of broader-spectrum antimicrobials than would have been optimal 268 (75%) Use of more costly agents 209 (58%) Use of second-line / less effective therapy 161 (45%) Use of more toxic antimicrobials than would have been optimal 132 (37%) Delayed treatment 54 (15%) Longer hospitalization 43 (12%) Slower clinical response 37 (10%) Use of compounded agents 22 (6%) Long-term morbidity from inadequate treatment of infection 16 (4%) Transfer patients to other facilities 10 (3%) Patient contracted disease that agent in short supply should have prevented 8 (2%) Other* 12 (3%) Most common response (by 57) was use of a broader-spectrum agents + use of more costly agents. *In open-text field, other adverse events listed were: two drugs instead of one (cefepime/flagyl) (by 3 respondents); actually, has facilitated time-outs that we prefer, limiting use of broadspectrum abx; except doxycycline which required alt agents determined but not necessarily less effective; pyrimethamine COULD affect us but has not to date ; C diff (by 1); changing surgical abx prophylaxis regimen (by 1); use of less tested agent in children (by 1), readmission to hospital when outpatient/long term care facility could not provide drug (by 1) Question 4. Have price increases for an antimicrobial agent resulted in your inability to prescribe an agent? Yes 176 (36%) No 319 (64%) Answered by 495 respondents *In open-text field, 157 respondents specified agent(s) or offered comments: Daraprim/pyrimethamine (by 38), doxycycline (by 34), linezolid (by 16), daptomycin (by 8), ribavirin (by 7), albendazole (by 6), ceftaroline (by 6), flucytosine (by 4), penicillin (by 3), primaquine (by 3), fidaxomicin (by 2), meropenem (by 2), minocycline (by 2) By 1 respondent each: atovaquone, cycloserine, erythromycin, Harvoni, hepatitis C drugs, itraconazole, ivermectin, mebendazole, moxifloxacin, oritavancin/dalbavancin, oxacillin, praziquantel, Tamiflu, telavancin, vancomycin oral A patient who received copay assistance for Baraclude is now unable to afford generic entecavir ; Encouraged to not use ampicillin for CAP in favor of cheaper ceftriaxone ; the insane price of albendazole makes therapy for patients without insurance unobtainable ; flucytosine - in hospital cost and out of hospital cost- pharmacies won t fill as Medicare reimburses only 600$ ; linezolid price isn't new, but we often can't prescribe it when we think it's the best drug Page 3
4 Question 5. Have you experienced a shortage of any vaccine within the past 2 years? Yes 94 (19%) No 401 (81%) Answered by 495 respondents *In open-text field, 89 respondents specified agent(s): or offered comments: Yellow fever (by 39), typhoid (by 15), influenza (by 8), influenza high dose (by 6), rabies (by 6), Pentacel (by 4), TDaP (by 3), Japanese encephalitis (by 3), influenza nasal/flumist (by 3), shingles/zoster (by 3), polio/ipv (by 2), Prevnar (by 2), meningococcal, including Menomune and Menactra (by 2) At the Federally Qualified Health Center, Vaccines for Children cannot be ordered in advance; you can restock but not order for any anticipated surge. This results in sending children home without scheduled vaccines when reordering is delayed or more patients than usual arrive. We don't have a solution. Communication about Agents in Short Supply Question 6. How do you currently learn about shortages? [Instructions were to select all that apply; numbers add to more than 100%; 493 respondents] Hospital/system notification (via pharmacy, P&T committee, stewardship) 377 (76%) Other communication from a colleague (MD, PharmD, etc) 277 (56%) Contact from a pharmacy after I tried to prescribe a drug in short supply 259 (53%) Listserv or social media (EIN, FDA MedWatch Safety Alerts, Twitter) 153 (31%) Website (FDA Drug Shortages or ASHP) 115 (23%) Mobile app (FDA Drug Shortages, RxShortages 26 (5%) Other 8 (2%) Most common response (by 70) was notification only from their hospital/system. *In open-text field, other sources of information were: Sanford mobile app, AAP , local health department, VA central / VISN pharmacy administration Question 7. Are current communications about drug shortage issues sufficient for your practice? Yes 349 (71%) No 142 (29%) Answered by 491 respondents Question 8. Has your institution developed any guidelines for prioritizing use of agents in short supply, or restrictions who can get an agent in short supply? Yes 408 (83%) No 50 (10%) Not sure 36 (7%) Answered by 494 respondents If yes, who was involved in the process? [Instructions were to select all that apply; numbers add to more than 100%; 377 respondents] You 195 (52%) Antimicrobial stewardship program 351 (93%) Page 4
5 Question 9. Does your institution a. switch to nonformulary agents when the formulary agent is in short supply? Yes 307 (62%) No 113 (23%) Not sure 74 (15%) Answered by 494 respondents b. seek supplies from other hospitals to provide agents in short supply? Yes 384 (78%) No 40 (8%) Not sure 70 (14%) Answered by 494 respondents Question 10. In the period since January 1, 2013 a. have you perceived any improvements in FDA s communication / notification about drug shortages? Yes 64 (13%) No 216 (44%) Not sure 214 (43%) Answered by 494 respondents b. have shortages for your practice become More frequent 298 (60%) Less frequent 36 (7%) No change 116 (24%) Not sure 44 (9%) Answered by 494 respondents Page 5
Responders as percent of overall members in each category: Region: New England 50 (58% of 86 members) 19 (51% of 37 members) 3 (33% of 9 members)
Infectious Diseases Society of America Emerging Infections Network Report for Query: Prosthetic Joint Infections (PJI) in Adults Overall response rate: 556/118 (4.2%) physicians responded from 5/16/12
More informationMONTEFIORE MEDICAL CENTER
DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September
More information21 (49% of 43 members) Both adult and pediatric 22 (34% of 65 members) Region: New England 54 (55% of 98 members) 288 (52% of 549 members)
9 December 01 Infectious Diseases Society of America Emerging Infections Network Report for Query: Use of Respiratory Protective Devices for Influenza Overall response rate: 686/1,7 (7%) physicians responded
More informationDrug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD
Antimicrobial Dosing in Renal Insufficiency (Adults) ASP Handbook * In patients on hemodialysis (), give antimicrobial immediately after dialysis on dialysis days. = Intermittent hemodialysis = Peritoneal
More informationResponders as percent of overall members in each category: Practice: Adult 537 (51% of 1063 members) 23 (59% of 39 members)
Infectious Diseases Society of America Emerging Infections Network Report for Query: Antibiotic Allergies and Infectious Disease Practice Overall response rate: 744/1411 (52.7%) physicians responded from
More informationResponders as percent of overall members in each category: Region: New England 50 (57% of 87 members) 46 (57% of 81 members) 21 (55% of 38 members)
Infectious Diseases Society of America Emerging Infections Network Report for Query: Recurrent C. difficile Infections (CDI) Overall response rate: 621/1212 (51.2%) physicians responded from 09/26/12 to
More informationChapter 5 ~ Infections
Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy
More information5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and
5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs
More informationAdult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016
Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology
More information2019 PHP PRIMARY CARE INCENTIVE
Primary Care Physicians (PCP) of Physicians Health Network (PHN) may be eligible for an incentive payment in accordance with this PHP PCP Incentive (hereinafter referred to as the PCP Incentive ). As described
More informationMIC Test Strip for antimicrobial susceptibility testing
for antimicrobial susceptibility testing Liofilchem Liofilchem Quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) is a quantitative assay for determining the Minimum Inhibitory
More informationOverall response rate: 701/1265 (55.4%) physicians responded from 3/4/09 to 3/30/09.
Infectious Diseases Society of America Emerging Infections Network 4/2/09 Report for Query: Travel and Tropical Medicine Overall response rate: 701/1265 (55.4%) physicians responded from 3/4/09 to 3/30/09.
More informationLaboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18
More informationAntibiotic Dosing in the Elderly
Antibiotic Dosing in the Elderly Philip Chung, PharmD, MS, BCPS Nebraska ASAP Community Network Pharmacy Coordinator Nebraska Medicine Disclosure I have no relevant disclosure The presentation includes
More informationAnnual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016
Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016 Sarah Gierhart and Uzo Chukwuma Approved for public release. Distribution is unlimited. The views
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationClinical Pearls Infectious Diseases. Pritish K. Tosh, MD MN ACP Nov 7, [Answers and discussion slides will be posted after the meeting]
Clinical Pearls Infectious Diseases Pritish K. Tosh, MD MN ACP Nov 7, 2014 [Answers and discussion slides will be posted after the meeting] Case 1 A 33-year-old male with diffuse large B-cell lymphoma
More informationADULT ANTIMICROBIAL DOSING TOOL (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017)
(NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017) Introduction The dosing recommendations presented here are for adults with moderate-to-severe infections and are
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationCanadian Nosocomial Infection Surveillance Program 2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING PEDIATRIC CARDIAC SURGERY
Canadian Nosocomial Infection Surveillance Program 2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING PEDIATRIC CARDIAC SURGERY December 29, 2016 FINAL Working Group: Bonita Lee (Chair), Joanne Langley,
More informationCEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins
Report generated from BNF - Local Information provided by FormularyComplete (www.pharmpress.com). Accessed 31 07 2017 Title Formulary Status Section Amikacin Non Formulary 5.1 Antibacterial drugs->5.1.4
More informationPK/PD degli antibiotici utilizzati nella sepsi
PK/PD degli antibiotici utilizzati nella sepsi Dario Cattaneo, U.O. Farmacologia Clinica ASST Fatebenefratelli Sacco, Milano Bergamo, città alta Variability of antibiotic concentrations in critically ill
More informationBlueMedicare SM Comprehensive Formulary
BlueMedicare SM Comprehensive Formulary BlueMedicare Complete Rx (PDP) S5904-002 BlueMedicare Group PPO (Employer PPO) BlueMedicare Group Rx (Employer PDP) BlueMedicare means more This formulary was updated
More informationThis letter authorises the extended use of the following guidance until 1st December 2018:
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date 29 1h May 2018 Our Ref FApenicillin/hype/MGPG/May 18 Enquiries to Frances Adamson Extension 56689 Direct Line 01224
More informationFORMULARY. (List of Covered Drugs) Molina Dual Options MyCare Ohio (Medicare-Medicaid Plan)
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options MyCare Ohio (Medicare-Medicaid Plan) Version 14 UPDATED: 11/2015 Member Services (855) 665-4623, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m.
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationFormulary. BlueMedicare SM Comprehensive. BlueMedicare Complete (HMO SNP) H ,028,029,030
BlueMedicare SM Comprehensive Formulary BlueMedicare Complete (HMO SNP) H1035-027,028,029,030 This formulary was updated on 03/22/. For more recent information or other questions, please contact Florida
More informationHospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing
Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Infections therapeutic group PTAC and Subcommittee of PTAC minutes are
More informationFormulary. BlueMedicare SM Comprehensive
BlueMedicare SM Comprehensive Formulary BlueMedicare Complete Rx (PDP) S5904-002 BlueMedicare Group PPO (Employer PPO) BlueMedicare Group Rx (Employer PDP) This formulary was updated on 12/31/2018. For
More informationRegence MedAdvantage + Rx Classic (PPO) and. Regence MedAdvantage + Rx Enhanced (PPO) 2018 Formulary (List of Covered Drugs)
Regence MedAdvantage + Rx Classic (PPO) and Regence MedAdvantage + Rx Enhanced (PPO) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS
More informationAsuris Medicare Script Enhanced (PDP) and. Asuris Medicare Script Basic (PDP) 2018 Formulary. (List of Covered Drugs)
Asuris Medicare Script Enhanced (PDP) and Asuris Medicare Script Basic (PDP) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN
More informationBeta lactam Allergies Facts vs. Fears
1 Beta lactam Allergies Facts vs. Fears Meghan Jeffres, PharmD Assistant Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy Statement of Disclosures 2 No financial
More informationNHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections
1 5. Infections Also see Primary Care and Hospital Antibiotic Guidance NHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections Management of Serious Infections in Paediatrics. Guidance
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
October, 08 Arkansas Blue Cross and Blue Shield Metallic Formulary 08 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
December, 08 Arkansas Blue Cross and Blue Shield Metallic Formulary 08 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies
More informationInfectious Disease Hot Topics: 2008
Infectious Disease Hot Topics: 2008 Joseph Domachowske MD Professor of Pediatrics, Microbiology and Immunology Golisano Children s Hospital at SUNY Upstate Medical University Topic 1: COMMUNITY-ASSOCIATED
More informationReport generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACICLOVIR Aciclovir 5.3 Antiviral drugs->5.3.2
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationRegence MedAdvantage + Rx Classic (PPO) and. (List of Covered Drugs)
Regence MedAdvantage + Rx Classic (PPO) and Regence MedAdvantage + Rx Primary (PPO) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationBlueMedicare SM Comprehensive Formulary
BlueMedicare SM Comprehensive Formulary BlueMedicare Complete (HMO SNP) H1026-063, 064, 065, 066 BlueMedicare means more This formulary was updated on 01/01/2018. For more recent information or other questions,
More informationAsuris Medicare Script Enhanced (PDP) 2019 Formulary (List of Covered Drugs)
Asuris Medicare Script Enhanced (PDP) Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File Submission ID
More informationAlaris System Profile Report RELEASED. Stepdown. VUMC - 3/18/ :20 Page 1 of 19 VUMC O, 018d997b6-R
Alaris System Profile Report RELEASED Stepdown VUMC - 3/18/2013 09:20 Page 1 of 19 1. Current Data Set Status Data Set Name Hospital Name Data Set ID Data Set Status VUMC 9.4 2013 O VUMC 018d997b6-R Released
More informationFormulary. BlueMedicare Classic (HMO) H , 020, 021 BlueMedicare Choice (Regional PPO) R BlueMedicare Value Rx (PDP) S
BlueMedicare SM Comprehensive Formulary BlueMedicare Classic (HMO) H1035-019, 020, 021 BlueMedicare Choice (Regional PPO) R3332-001 BlueMedicare Value Rx (PDP) S5904-006 This formulary was updated on 10/9/2018.
More informationRed Book : Errata. (Revised 12/15/03)
Red Book : 2003 REPORT OF THE COMMITTEE ON INFECTIOUS DISEASES Errata (Revised 12/15/03) For the most up-to-date list of important Red Book errata, please visit the Red Book Online Web site at http://www.aapredbook.org.
More informationFormulary. BlueMedicare Preferred (HMO) H , 004, 006 BlueMedicare Preferred POS (HMO POS) H
BlueMedicare SM Comprehensive Formulary BlueMedicare Preferred (HMO) H2758-002, 004, 006 BlueMedicare Preferred POS (HMO POS) H2758-008 This formulary was updated on 12/28/2018. For more recent information
More informationTable 2. Microbial causes of infections according to site, and type of host, and recommended empiric antimicrobial therapy.
Table 2. Microbial causes of infections according to site, and type of host, and recommended empiric antimicrobial therapy. Newborn Site of Infections Organisms Antimicrobials Sepsis, Meningitis Streptococcus
More information2019 Formulary List of Covered Drugs. Passport Advantage (HMO SNP) ADVANTAGE (HMO SNP)
ADVANTAGE (HMO SNP) Passport Advantage (HMO SNP) 2019 Formulary List of Covered Drugs PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File
More informationDry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.
Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole
More informationPenetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2010, p. 858 883 Vol. 23, No. 4 0893-8512/10/$12.00 doi:10.1128/cmr.00007-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Penetration of Drugs
More informationOrchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department
Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Dr. Eugene Tso Division of Infectious Diseases Department of Medicine & Geriatrics United Christian Hospital 11 May 2010
More informationDecember 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide
Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,
More information2019 Abridged Formulary Partial List of Covered Drugs. Passport Advantage (HMO SNP) ADVANTAGE (HMO SNP)
ADVANTAGE (HMO SNP) Passport Advantage (HMO SNP) 2019 Abridged Formulary Partial List of Covered Drugs PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT SOME OF THE DRUGS WE COVER IN THIS PLAN HPMS
More informationFormulary. BlueMedicare SM Comprehensive
BlueMedicare SM Comprehensive Formulary BlueMedicare Classic (HMO) H1035-017,018 BlueMedicare Classic Plus (HMO) H1035-022 BlueMedicare Select (PPO) H5434-002 This formulary was updated on 12/31/2018.
More informationAPPENDIX: NATIONAL SURVEILLANCE DATA AND TRENDS
2008 Annual Surveillance Report Notifiable and Other s in New Zealand 49 APPENDIX: NATIONAL SURVEILLANCE DATA AND TRENDS COMPARISON OF NOTIFIABLE DISEASE CASES AND RATES FOR 2007 AND 2008 Table 37. Number
More informationBlueMedicare SM Comprehensive Formulary
BlueMedicare SM Comprehensive Formulary BlueMedicare Classic (HMO) H1026-040, 056, 057 BlueMedicare Choice (Regional PPO) R3332-001 BlueMedicare means more This formulary was updated on 01/01/2018. For
More informationHandbook of Antimicrobial Therapy
Handbook of Antimicrobial Therapy Selected Articles from Treatment Guidelines with updates from The Medical Letter Published by The Medical Letter, Inc. 145 Huguenot St. New Rochelle, New York 10801-7537
More informationBackground. Background. Background 3/14/2014. Conflict of Interest Statement:
Platform Presentations Comparison of zolpidem to other drugs associated with falls in hospitalized patients Ed Rainville, MSPharm. Conflict of Interest Statement: The speaker has no conflict of interest
More informationAlabama Medicaid Pharmacist
Alabama Medicaid Pharmacist Published Quarterly by Health Information Designs, LLC, Winter 015 edition A Service of Alabama Medicaid PDL Update Effective January 5, 015, the Alabama Medicaid Agency will
More information2018 Formulary. (List of Covered Drugs)
Capital Health Plan Retiree Advantage (HMO) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary ID 00018125,
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More information1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017
To support national and global efforts to increase access to and the affordability of care and treatment of HIV/AIDS, hepatitis B and C, tuberculosis, malaria, neglected tropical diseases, influenza, diarrhoea
More information2018 Formulary. (List of Covered Drugs)
Capital Health Plan Advantage Plus (HMO) Capital Health Plan Preferred Advantage (HMO) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN
More informationMedi-Pak Advantage (PFFS)
Medi-Pak Advantage (PFFS) 2018 Comprehensive Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Formulary 00018143, version 15 This
More information2019 Bright Formulary. (List of Covered Drugs) Bright Health Individual and Family Plans. Arizona Maricopa
2019 Bright Formulary (List of Covered Drugs) Bright Health Individual and Family Plans Arizona Maricopa Gold Silver Silver Perks Silver Direct Silver Perks Direct Bronze Bronze Perks Bronze HSA PLEASE
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationPenicillin Allergy Guidance Document
Key Points Penicillin Allergy Guidance Document Background Careful evaluation of antibiotic allergy and prior tolerance history is essential to providing optimal treatment The true incidence of penicillin
More informationJuly 2011 IN THIS ISSUE:
July 2011 IN THIS ISSUE: Mass Spectrometry Pg 2 VITEK 2 PC5.01 Pg 3 Henry Ford Hospital Pg 5 ProLab Pg 6 New VITEK 2 Cards Pg 8 Total AST Pg 11 Events Calendar Pg 12 Mass Spectrometry: Cutting Edge Microbial
More informationOPAT Community and Outcomes: The OPAT Service Directory and National Outcomes Registry
OPAT Community and Outcomes: The OPAT Service Directory and National Outcomes Registry For enquiries/support: Service Directory in Action! Can BSAC sort out daily antibiotics? GP R OPAT Community and
More informationgram neg.(semisynthetic) Bacteria Drugs that inhibit cell wall synthesis Drug Action Organisms Comments Spectrum of Action Mycobacterium
Mickey Dufilho s Drugs and Bugs Revised 10/10/15 Bacteria Drugs that Inhibit Cell Wall Synthesis Drug Action Spectrum of Action Comments Spectrum of Action Bacitracin Beta-Lactam antibiotics Penicillin
More informationCARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated
More information2017 Formulary. (List of Covered Drugs)
Capital Health Plan Advantage Plus (HMO) Capital Health Plan Preferred Advantage (HMO) 2017 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN
More informationAntimicrobial Reference Laboratory
Antimicrobial Reference Laboratory GUIDELINE RANGES FOR TDM 2018 Andrew Lovering Antimicrobial Reference Laboratory North Bristol NHS Trust Southmead Hospital Bristol, BS10 5NB Guideline Ranges 2018 Aminoglycosides
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationEnhanced Plan 2018 Prescription Drug Formulary. (Comprehensive list of covered drugs)
Enhanced Plan 2018 Prescription Drug Formulary (Comprehensive list of covered drugs) HPMS Approved Formulary File Submission ID 18119, Version Number 11 Please Read: This document contains information
More informationHorizon Blue Cross Blue Shield of New Jersey. Horizon Medicare Blue Rx Enhanced (PDP) 2018 Formulary. (List of Covered Drugs)
Horizon.., Horizon Blue Cross Blue Shield of New Jersey Horizon Medicare Blue Rx Enhanced (PDP) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE
More informationUniversity of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology
University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational
More informationIBM Health Plan. Formulary 2018 VITAL, VIBRANT, VIBRA. List of Covered Drugs
IBM Health Plan Medicare Advantage PPO Vibra Health Plan Essential Coverage PPO Vibra Health Plan Enhanced Coverage PPO Formulary 2018 List of Covered Drugs PLEASE READ: This document contains information
More informationOther β-lactam. A. Carbapenems:
A. Carbapenems: Other β-lactam Carbapenems are synthetic β-lactam antibiotics Differ in structure from the penicillins in that the sulfur atom of the thiazolidine ring. Imipenem, meropenem, doripenem,
More information2019 Formulary. (List of Covered Drugs)
Capital Health Plan Retiree Advantage (HMO) 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary ID 00019182,
More information2016 Prescription Drug Guide
2016 Prescription Drug Guide Humana Medicare Employer Plan Formulary List of covered drugs Humana Group Medicare Plus 1 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationCritical Time Medication Procedure
Ref:PharmMM74 Critical Time Medication Procedure INITIATED BY: APPROVED BY: DATE APPROVED: Suzanne Scott-Thomas, Amanda Halloway Endorsed by Medication Safety Committee Sept 2011 VERSION: 1.1 OPERATIONAL
More informationFoot infections are now among the most
Article Progress in a pedestrian problem: A review of the revised Infectious Diseases Society of America diabetic foot infection guidelines Benjamin A Lipsky This article was first published in The Diabetic
More informationHorizon Blue Cross Blue Shield of New Jersey. Horizon Medicare Blue (PPO) 2018 Formulary. (List of Covered Drugs)
.., Horizon Blue Cross Blue Shield of New Jersey Horizon Medicare Blue (PPO) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationCOMPOUNDED STERILE PREPARATIONS RECONSTITUTION, DILUTION AND STABILITY CHART (ADULT)
FH Pharmacy Department ACYCLOVIR 3 (PPC) AMIKACIN 2,3 AMPHOTERICIN B 1,4 (Fungizone ) AMPHOTERICIN B 1.3 Lipid Complex (Abelcet ) AMPHOTERICIN B 1.3 Liposomal (Ambisome ) AMPICILLIN 1,3 (Teva, PPC) ARGATROBAN
More information